ID   NOS3AR
AC   CVCL_RN34
DR   Wikidata; Q54930923
RX   PubMed=8097673;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T746 ! NOS3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 5
//
RX   PubMed=8097673;
RA   Maeda, Osamu
RA   Terasawa, Motomu
RA   Ishikawa, Tomohiko
RA   Oguchi, Hidenori
RA   Mizuno, Kimio
RA   Kawai, Michiyasu
RA   Kikkawa, Fumitaka
RA   Tomoda, Yutaka
RA   Hidaka, Hiroyoshi
RT   "A newly synthesized bifunctional inhibitor, W-77, enhances adriamycin
RT   activity against human ovarian carcinoma cells.";
RL   Cancer Res. 53:2051-2056(1993).
//